Rachel Issaka, MD, MAS

/content/dam/www/faculty-photos/I/rachel-issaka/Rachel-Issaka.jpg
Dr. Rachel Issaka MD, MAS
faculty member

Rachel Issaka, MD, MAS

Associate Professor, Public Health Sciences Division, Fred Hutch

Associate Professor
Public Health Sciences Division, Fred Hutch

Associate Professor, Gastroenterology and Hepatology, Clinical Research Division, Fred Hutch

Associate Professor, Gastroenterology and Hepatology
Clinical Research Division, Fred Hutch

Associate Professor, Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutch

Associate Professor
Hutchinson Institute for Cancer Outcomes Research (HICOR), Fred Hutch

Kathryn Surace-Smith Endowed Chair in Health Equity Research, Fred Hutch

Kathryn Surace-Smith Endowed Chair in Health Equity Research
Fred Hutch

Fax: 206.667.5977
Mail Stop: M3-B232

Dr. Rachel Issaka is a gastroenterologist and clinical researcher focused on decreasing the mortality associated with colorectal cancer, with a special focus on medically underserved populations. Dr. Issaka’s research includes identifying, measuring and recommending new and improved approaches to screening and follow-up both in Seattle and across the U.S.

Other Appointments & Affiliations

Director, Population Health Colorectal Cancer Screening Program, Fred Hutch & UW Medicine

Director, Population Health Colorectal Cancer Screening Program
Fred Hutch & UW Medicine

Associate Professor, Department of Internal Medicine; Division of Gastroenterology, University of Washington School of Medicine

Associate Professor, Department of Internal Medicine; Division of Gastroenterology
University of Washington School of Medicine

Education

Fellowship, Gastroentereology and Hepatology, University of California, San Francisco, 2017

MAS, Clinical Research, University of California, San Francisco, 2017

Residency, Internal Medicine, McGaw Medical Center of Northwestern University, 2013

MD, University of Michigan, 2010

BS, Biology, University of Wisconsin-Eau Claire, 2005

Research Interests

Optimizing interventions that improve colorectal cancer care outcomes

Achieving health equity in colorectal cancer care in medically underserved populations

Colorectal cancer screening as a model for precision population health

"Screening is a way to not only prevent disease but reduce racial and economic disparities. We need to close that gap so that every citizen can benefit from the advances in cancer care and prevention."

— Dr. Rachel Issaka

Find a Clinical Trial Led by Dr. Issaka